SCHEMBL15782857

SCHEMBL15782857

CCc1c(C(C)=O)c(O)cc2cccnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
PDE4A P27815 1/20 0.42
KDM4E B2RXH2 7/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
HTT P42858 1/20 0.40
CASP6 P55212 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
COMT P21964 3/20 0.40
MMP2 P08253 1/20 0.40
CHRM1 P11229 1/20 0.40
TSHR P16473 1/20 0.40
ADRA1A P35348 1/20 0.40
METAP2 P50579 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19841040 0.87 ALDH1A1 (0.43) ALDH1A1PDE4AKDM4ENPC1RAB9A
SCHEMBL15782878 0.76 TRPM4 (0.47) ALDH1A1KDM4EMAPTTDP1MEN1
SCHEMBL31022679 0.72 ERN1 (0.54) ALDH1A1KDM4EMAPTNFKB1HTT
SCHEMBL21569600 0.70 ALDH1A1 (0.41) ALDH1A1PDE4AKDM4ENPC1RAB9A
SCHEMBL13943225 0.70 ALDH1A1 (0.51) ALDH1A1PDE4AKDM4ENPC1RAB9A
SCHEMBL25702612 0.69 HSP90AA1 (0.54) PDE4AKDM4ENPC1RAB9AMAPT
SCHEMBL686939 0.69 KDM4E (0.53) KDM4ENPC1RAB9AMAPTPKM
Oxyquinoline SCHEMBL3950361 0.68 COMT (0.70) ALDH1A1KDM4ERAB9AMAPTNFKB1
SCHEMBL19841046 0.68 MEN1 (0.48) KDM4EMAPTSMN1; SMN2ALOX12MEN1
SCHEMBL17826657 0.67 THRB (0.52) MAPTPKMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160340325-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-11-24 US disclosed
EP-1753713-B1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF HARVARD COLLEGE (US) 2016-07-27 EP disclosed
US-9365493-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-06-14 US disclosed
US-20140163238-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163238-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF TET1, TET3, MYC ALDH1A1 4455/4885PDE4A 4622/4885KDM4E 800/4885
US-20160340325-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF TET1, TET3, MYC ALDH1A1 4455/4885PDE4A 4622/4885KDM4E 800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.